Proton Partners International Revenue and Competitors

Newport,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Proton Partners International's estimated annual revenue is currently $30.8M per year.(i)
  • Proton Partners International's estimated revenue per employee is $270,000

Employee Data

  • Proton Partners International has 114 Employees.(i)
  • Proton Partners International grew their employee count by 30% last year.

Proton Partners International's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$54.4M1836%N/AN/A
#2
$18M74-4%N/AN/A
#3
$162.7M48239%N/AN/A
#4
$42.8M1448%N/AN/A
#5
$26.5M984%N/AN/A
#6
$33.2M123-2%N/AN/A
#7
$29.7M11012%N/AN/A
#8
$15.5M66-21%$29.7MN/A
#9
$1645.8M435413%N/AN/A
#10
$43.7M14718%N/AN/A
Add Company

What Is Proton Partners International?

Proton Partners International is at the vanguard of advancing cancer care, building a series of oncology centres known as the Rutherford Cancer Centres. Offering world-class proton beam therapy, along with diagnostics, chemotherapy, radiotherapy, and holistic therapy, treatment at the centres will be available to medically-insured private patients, self-paying patients and patients referred by the NHS. Our South Wales centre has already opened and will be the first location in the UK to offer high energy proton beam therapy (March 2018). Centres in Northumberland, Reading and Liverpool are also in development.

keywords:N/A

N/A

Total Funding

114

Number of Employees

$30.8M

Revenue (est)

30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Proton Partners International News

2022-04-20 - From GCP to RPA

Enslin is credited with building Google Cloud's international ... “These changes will put our resources closer to customers and partners,...

2022-04-19 - Proton Therapy Market Future Demand, Business Strategies ...

Global proton therapy market has been witnessing increasing collaboration activities with technology partners wherein companies are vying for integrating...

2022-04-17 - Porton and Sinorda partner to develop cell and gene therapies

Proton Advanced CEO Dr Yangzhou Wang said: “Sinorda Biomedicine has ... Sinorda, which has expertise in domestic and international new drug...

2019-06-10 - Proton Partners International: Protons to Play a Vital Role in the Battle Against Prostate Cancer

MANCHESTER, England, June 10, 2019 /PRNewswire/ -- An upsurge in demand for proton beam therapy was predicted today as the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$31.6M1174%N/A
#2
$32.4M1203%N/A
#3
$33.2M12315%N/A
#4
$21.4M12348%N/A
#5
$31.4M125-24%N/A